Lv11
30 积分 2022-10-09 加入
Tertiary lymphoid structures in anticancer immunity
1天前
已完结
Sustained innate interferon is an essential inducer of tertiary lymphoid structures
23天前
已完结
LTβR Agonism Promotes Antitumor Immune Responses via Modulation of the Tumor Microenvironment
23天前
已完结
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
4个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
10个月前
已完结
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
1年前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting Delta-like ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
1年前
已完结
BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control
2年前
已关闭
TGF-β antagonizes IFN-γ-mediated adaptive immune evasion via activation of the AKT-Smad3-SHP1 axis in lung adenocarcinoma
2年前
已完结
Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases
2年前
已完结
皖公网安备34019202002308
